National Comprehensive Cancer Network



About NCCN

Non-Hodgkin`s Lymphomas Panel - Disclosures as of 7/15/2011

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Scientific Advisory Boards, Consultant, or Expert Witness Promotional Advisory Boards, Consultant, or Speakers Bureau Employment/ Governing Board, Patent, Equity, or Royalty Spouse/Domestic Partner/Dependent Potential Conflict

Jeremy S. Abramson, MD

None

Celgene Corporation;
Genentech, Inc.;
Genzyme Corporation

None

None

None

Ranjana H. Advani, MD

None

Genentech, Inc.;
Allos Therapeutics;
Pharmacyclics Inc.;
Seattle Genetics

None

None

None

C. Babis Andreadis, MD, MSCE

None

Allos

None

None

Roche Laboratories, Inc.

Nancy Bartlett, MD

None

None

None

None

None

Naresh Bellam, MD, MPH

None

None

None

None

None

R. Gregory Bociek, MD, MSc

None

None

None

None

None

John C. Byrd, MD

None

None

None

None

None

Myron S. Czuczman, MD

None

Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
GlaxoSmithKline

None

None

None

Mary Dwyer, MS

None

None

None

None

None

Luis E. Fayad, MD

Centocor, Inc.;
Eli Lilly and Company;
Genentech, Inc.;
GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Pfizer Inc.;
Roche Laboratories, Inc.;
Wyeth Pharmaceuticals

None

None

None

None

Lauren Gallagher, RPh, PhD

None

None

None

None

None

Martha J. Glenn, MD

None

None

None

None

None

Jon P. Gockerman, MD

None

Novartis Pharmaceuticals Corporation

None

None

None

Leo I. Gordon, MD

None

CureTech Ltd.

None

CureTech Ltd.

None

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

None

Nancy Lee Harris, MD

None

None

None

None

None

Richard T. Hoppe, MD

None

None

None

None

None

Steven M. Horwitz, MD

None

Bristol-Myers Squibb Company;
Celgene Corporation;
Genzyme Corporation;
Merck & Co., Inc.;
Novartis Pharmaceuticals Corporation;
Allos;
Seattle Genetics

None

None

None

Christopher R. Kelsey, MD

None

None

None

None

None

Youn H. Kim, MD

None

Celgene Corporation;
Merck & Co., Inc.;
Millennium Pharmaceuticals, Inc.;
Allos therapeutics;
Kyowa

None

None

None

Susan Krivacic, MPAff

None

None

None

None

None

Ann S. LaCasce, MD

None

None

None

None

None

Joan S. McClure, MS

None

None

None

None

None

Auayporn Nademanee, MD

None

Spectrum Phamaceuticals

None

None

None

Pierluigi Porcu, MD

None

Therakos, Inc.

None

None

None

Oliver Press, MD, PhD

None

Millennium Pharmaceuticals, Inc.;
Algeta;
Emergent Biosolutions;
Inimex;
Zymogenetics;
Roche Laboratories, Inc.

None

Emergent Biosolutions

None

Barbara Pro, MD

None

None

None

None

None

Nishitha Reddy, MD

None

None

None

None

None

Lubomir Sokol, MD, PhD

None

Alexion Pharmaceuticals, Inc.;
Celgene Corporation;
Celgene Corporation;
Eisai Inc.;
Eisai Inc.;
MedImmune Inc.;
Allos

None

None

None

Lode J. Swinnen, MB, ChB

None

None

None

None

None

Christina Tsien, MD

None

None

None

None

None

Julie M. Vose, MD, MBA

None

None

None

None

None

William G. Wierda, MD, PhD

None

Celgene Corporation;
Genentech, Inc.;
Micromet;
Roche Laboratories, Inc.

None

None

None

Joachim Yahalom, MD

None

None

None

None

None

Nadeem Zafar, MD

None

None

None

None

None

Andrew D. Zelenetz, MD, PhD

None

Abbott Laboratories;
Celgene Corporation;
Cephalon, Inc.;
Genentech, Inc.;
Genentech, Inc.;
GlaxoSmithKline;
Allos;
Cancer Genetics;
Seattle Genetics;
Roche Laboratories, Inc.;
sanofi-aventis U.S.

None

None

None